Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma
Cancer Biomarkers · 2024
DOI: 10.3233/cbm-230325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, 2024. Verfasst von Wuping Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Lymphatic and Hematological Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Ferroptosis, Lymphoma, Large B-Cell, Diffuse, Biomarkers, Tumor. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: Therapies for diffuse large B-cell lymphoma (DLBCL) are limited due to the diverse gene expression profiles and complicated immune microenvironments, making it an aggressive lymphoma. Beyond this, researches have shown that ferroptosis contributes to tumorigenesis, progression, and metastasis. We thus are interested to dissect the connection between ferroptosis and disease status of DLBCL. We aim at generating a valuable prognosis gene signature for predicting the status of patients of DLBCL, with focus on ferroptosis-related genes (FRGs). OBJECTIVE: To examine the connection between ferroptosis-related genes (FRGs) and clinical outcomes in DLBCL patients based on public datasets. METHODS: An expression profile dataset for DLBCL was downloaded from GSE32918 ( https://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=gse32918 ), and a ferroptosis-related gene cluster was obtained from the FerrDb database ( http://www. zhounan.org/ferrdb/ ). A prognostic signature was developed from this gene cluster by applying a least absolute shrinkage and selection operator (LASSO) Cox regression analysis to GSE32918, followed by external validation. Its effectiveness as a biomarker and the prognostic value was determined by a receiver operator characteristic curve mono factor analysis. Finally, functional enrichment was evaluated by the package Cluster Profiler of R. RESULTS: Five ferroptosis-related genes (FRGs) ( GOP1, GPX2, SLC7A5, ATF4, and CXCL2) associated with DLBCL were obtained by a multivariate analysis. The prognostic power of these five FRGs was verified by TCGA ( https://xenabrowser.net/datapages/?dataset=TCGA.DLBC.sampleMap%2FHiSeqV2_PANCAN&host=https%3A%2F%2Ftcga.xenahubs.net&removeHub=https%3A%2F%2Fxena.treehouse.gi.ucsc.edu%3A44 ) and GEO ( https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=gse 32918 ) datasets, with ROC analyses. KEGG and GO analyses revealed that upregulated genes in the high-risk group based on the gene signature were enriched in receptor interactions and other cancer-related pathways, including pathways related to abnormal metabolism and cell differentiation. CONCLUSION: The newly developed signature involving GOP1, GPX2, SLC7A5, ATF4, and CXCL2 has the potential to serve as a prognostic biomarker. Furthermore, our results provide additional support for the contribution of ferroptosis to DLBCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Lymphatic and Hematological Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi, China.
- Queen Mary College of Nanchang University, Nanchang, Jiangxi, China.
Zitieren
APA
Li, W., Yao, R., Yu, N., & Zhang, W. (2024). Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma. Cancer Biomarkers. https://doi.org/10.3233/cbm-230325
Vancouver
Li W, Yao R, Yu N, Zhang W. Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma. Cancer Biomarkers. 2024. doi:10.3233/cbm-230325
BibTeX
@article{Li2024,
author = {Li, Wuping and Yao, Ruizhe and Yu, Nasha and Zhang, Weiming},
title = {Identification of a prognostic signature based on five ferroptosis-related genes for diffuse large B-cell lymphoma},
journal = {Cancer Biomarkers},
year = {2024},
doi = {10.3233/cbm-230325}
}
EUVIMED